“Based on our long history in sleep therapy innovation, we know that it can be hard for OSA patients to stick with therapy, but the first challenge is getting them diagnosed,” said Mark Aloia, senior director of global clinical research of Philips. “There are a substantial amount of people that have classic signs of OSA, but still remain undiagnosed, and a lot of the time it is because they don’t know that their restlessness at night isn’t normal.”
Visit SendMeToSleep.com to get inspired for slumber or take part in the conversation by following #SendMeToSleep on Twitter: @PhilipsHealth and @PhilipsResp, and Philips Respironics on Facebook.
Ad Statistics
Times Displayed: 22687
Times Visited: 478 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
1http://www.stopbang.ca/osa/prevalence.php
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 104,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.
Back to HCB News
